AI Article Synopsis
Article Abstract
A mucinous cystadenoma of the mesentery and two borderline mucinous cystadenocarcinomas of the mesentery and retroperitoneum are reported. The patients were females, aged 38, 47 and 58 years. The cysts showed identical features to those commonly seen in the appendix and ovary. One of our cases, with 'borderline' histology, developed metastases to mediastinal lymph nodes, 4 years after diagnosis. We suggest that these tumours develop through mucinous metaplasia in pre-existing mesothelium-lined cysts, the latter being the commonest cysts in this location.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-2559.1988.tb01972.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Abdominal lymphangioleiomyomatosis in a man presenting with gastrointestinal hemorrhage as the first manifestation: a case report.
Front Med (Lausanne)
December 2024
Department of Gastroenterology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.
Lymphangioleiomyomatosis (LAM) is a rare, low-grade malignant condition that typically affects women of childbearing age and primarily involves the lungs. While cases involving males and affecting the gastrointestinal tract are exceedingly uncommon. This report discusses an unusual case of abdominal LAM in a male patient with gastrointestinal hemorrhage.
View Article and Find Full Text PDFDedifferentiated recurrent liposarcoma of the uterine corpus: A case report and literature review.
Case Rep Womens Health
December 2024
Department of Gynecology, General Hospital of Ningxia Medical University, Yinchuan 750004, China.
Article Synopsis
- Liposarcoma of the uterine corpus is an extremely rare tumor with distinctive characteristics and treatment difficulties, as shown in a case study of a 57-year-old woman.
- The patient initially had surgery and chemotherapy after presenting with severe abdominal issues, but faced multiple recurrences over the following years, including a more aggressive form of the tumor.
- This case emphasizes the need for careful monitoring and individualized treatment plans to tackle the aggressive behavior of recurrent liposarcoma, particularly when it transforms into a dedifferentiated form.
Silent Giant: A Case of Dedifferentiated Retroperitoneal Liposarcoma Presenting as an Incidental Mesenteric Mass.
Cureus
October 2024
General Surgery, Sharon Regional Medical Center, Sharon, USA.
Article Synopsis
- - Dedifferentiated liposarcoma (DDL) is a rare and aggressive subtype typically found in the retroperitoneum, with challenging diagnostics, especially when it occurs in the mesentery as documented in very few cases.
- - A 76-year-old woman was discovered to have a large mesenteric mass incidentally while being treated for pneumonia, leading to surgery where a tumor adherent to the intestine was removed and identified as intermediate-grade DDL.
- - The case emphasizes the need to include mesenteric DDL in the differential diagnosis of large abdominal masses, highlighting that complete surgical resection is crucial for treatment, alongside regular follow-ups due to its aggressive nature.
A new technique of primary retroperitoneal approach for minimally invasive surgical treatment of cecal colon cancer with d3 lymph node dissection.
Tech Coloproctol
October 2024
Department of Faculty Surgery, No. 2, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Article Synopsis
- * A single-port system was utilized for dissection around key anatomical landmarks, including Toldt’s and Gerota’s fascia, which facilitated access to the ileocolic vessels and lymph nodes while minimizing complications associated with past surgical adhesions.
- * The operation lasted 240 minutes with minimal blood loss and low postoperative pain, indicating that this approach is safe and effective, allowing for successful treatment of cecal colon cancer and ensuring a manageable recovery time of 7 days
Split-Course Adaptive Radioimmunotherapy for Oligometastatic Non-Small Cell Lung Cancer (SiCARIO): A Case Report.
Cureus
September 2024
Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, USA.
Article Synopsis
- Current treatments for oligometastatic non-small cell lung cancer (NSCLC) mainly involve systemic chemotherapy and immune checkpoint inhibitors, but there's a need for better methods due to common recurrences.* -
- The first case using the Ethos OART platform for delivering targeted radiotherapy was presented, involving a 67-year-old man with stage IV NSCLC and multiple metastatic sites.* -
- The treatment utilized advanced planning techniques and adaptive strategies, resulting in over 80% tumor shrinkage and highlighting the potential benefits of this approach, though further research is necessary to establish its safety and efficacy.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!